awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57232070-0635DFF3-CA1F-47B5-8CBE-9EC5D91B8487
Q57232070-0635DFF3-CA1F-47B5-8CBE-9EC5D91B8487
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57232070-0635DFF3-CA1F-47B5-8CBE-9EC5D91B8487
Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma
P2860
Q57232070-0635DFF3-CA1F-47B5-8CBE-9EC5D91B8487
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57232070-0635DFF3-CA1F-47B5-8CBE-9EC5D91B8487
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d9826d1c6260860e581f5dbd39b0572ff41a3fd
P2860
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.